Boltz2ESI is introduced, an end-to-end framework that predicts enzyme–substrate interactions by leveraging structural knowledge learned by a biomolecular foundation model and consistently outperforms state-of-the-art sequence-based and rigid-docking approaches.
Abstract
Enzymatic catalysis relies on precise structural and chemical complementarity, yet systematically mapping enzyme-substrate interactions remains a critical bottleneck. While structure-aware methods have advanced functional annotation, their reliance on predefined binding pockets and rigid-body docking fails to capture the ligand-induced conformational changes essential for catalytic turnover. Here we introduce Boltz2ESI, an end-to-end framework that predicts enzyme–substrate interactions by leveraging structural knowledge learned by a biomolecular foundation model. Through native co-folding, the framework inherently captures active-site plasticity without requiring predefined pocket annotations. Integrating these learned biophysical priors with global evolutionary context and geometric molecular descriptors, Boltz2ESI consistently outperforms state-of-the-art sequence-based and rigid-docking approaches. Extensive validation demonstrates that the framework accurately discriminates tight sub-family specificities, enabling effective candidate prioritization for biosynthetic pathway elucidation, as demonstrated on the withanolide pathway. Ultimately, this structure-dynamic approach establishes an actionable foundation for accelerating rational biocatalyst discovery and large-scale pathway de-orphaning.
This work uncovers key dynamic features of the static and recognition pathway interaction of the ornithine decarboxylase-antizyme isoforms system and reveals critical determinants of binding specificity and partner selection that static structures alone cannot capture.
Baolin Guo, Qian Xue, Fan Yang et al.· Journal of Chemical Informat...· 0 citations
A structural database that systematically maps the complete activation trajectories of pharmaceutically relevant targets, encompassing TS, IS, and all connecting conformational ensembles is presented, offering multiple strategic advantages for drug discovery.
Co-folding models hold immense potential for allosteric drug discovery, but have been severely hampered by their systematic bias toward orthosteric ligand binding. While fragment screening has been proposed for allosteric binding site discovery, we show that co-folding models still suffer from memorization in which che...
Justin Purnomo, Kunyang Sun, T. Head-Gordon· bioRxiv· 0 citations
LinkerBridge is proposed, an equivariant framework that unifies biochemical semantics with physical constraints through two innovations: a Contextual Interaction-Aware Representation module that internalizes pre-existing bio-chemical semantics and a Differentiable Physical Guidance mechanism derived from Van der Waals...
Meng-Wei Sun, Chengwei Ai, Xiao-Yi Liu et al.· Proceedings of the Thirty-Fi...· 0 citations
This work introduces a two-stage generative diffusion modeling framework designed to support pathway discovery in protein complexes, demonstrated using RAF kinase dimerization, a key event for kinase activation and oncogenic signaling.
Tim Hsu, Konstantia Georgouli, Michael C. Jones et al.· Machine Learning: Science an...· 0 citations
A computational, structure-, dynamics-, and energetics-resolved framework for cyclic peptide recognition at the PP2A-B55α regulatory groove is established and testable hypotheses for experimental validation are defined.
Muhammad Waqas, Li Xuan, Haoke Zhang et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.